Table 4.
MIM | Name | Clinical Features | Prevalence | Inheritance | Gene |
---|---|---|---|---|---|
#168605 | Perry sydrome | The earliest and most prominent symptom may be MD not responsive to antidepressant drugs or electroconvulsive therapy. Sleep disturbances, exhaustion, and marked weight loss are features. | Eight families in the world | Dominant | DCTN1 |
#314250 | Dystonia 3, torsion, X-linked; DYT3 | The odds ratio for overall MD was increased OR = 2.85, 95% CI = 0.56–5.14) in patients with DYT3 compared to the control group. | 5.24 in 100,000 on Panay Island, Philippines | X-linked | TAF1 |
#128100 | Dystonia 1, torsion, autosomal dominant; DYT1 | Carriers of DYT1 are over four times more likely than noncarriers to exhibit recurrent MD. Relative risk of 3.62 | In France, an estimated disease frequency of 0.13 in 100,000 | Dominant | DYT1 |
#222300 | Wolfram syndrome 1; WFS1 | Additional clinical features include diverse psychiatric disorders | Heterozygous carriers of the Wolfram syndrome, estimated to represent approximately 1% of the United States population, are predisposed to MD. | Recessive | WFS1 |
The column headed MIM provides the reference number in Mendelian Inheritance in Man (http://www.omim.org).